Tey, S-K
Davenport, M P
Hill, G R
Kennedy, G A
Durrant, S T
Khanna, R
Cromer, D
Article History
First Online: 17 November 2014
Competing interests
: RK holds an international patent on CMV epitopes, which are included in the QuantiFERON-CMV kit. These epitopes are licensed to Cellestis Inc. for their inclusion in the QuantiFERON-CMV kit. International Patent on Human Cytomegalovirus Immunotherapy (Inventors listed: RK), granted and maintained in the USA (patent No. 7524503), Australia (No. 2002312654), Japan (No. 4574166) and under application in Europe (EP02737666.4). In addition, RK has also acted as a consultant for Cellestis Inc. for the development of QuantiFERON-CMV assay. Cellestis had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The remaining authors declare no conflict of interest.